Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.
about
Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.Role of cardiac renin angiotensin system in ischemia reperfusion injury and preconditioning of heartAngiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in miceChanges in levels of angiotensin II and its receptors in a model of inverted stress-induced cardiomyopathy.The preventive effects of diminazene aceturate in renal ischemia/reperfusion injury in male and female rats.Short-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy.Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis.Activation of the Neuroprotective Angiotensin-Converting Enzyme 2 in Rat Ischemic Stroke.ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease TherapyDiminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease.Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice.ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium.Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia.Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors.Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart FailureAssociation of exercise training and angiotensin-converting enzyme 2 activator improves baroreflex sensitivity of spontaneously hypertensive ratsDiminazene aceturate: an antibacterial agent for Shiga-toxin-producing Escherichia coli O157:H7.Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitroThe vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in rats.Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice.Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglycaemic rats.Coupling corticotropin-releasing-hormone and angiotensin converting enzyme 2 dampens stress responsiveness in male mice.Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetes.Sex-Specific Changes in Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Gene Expression and Enzyme Activity at Birth and Over the First Year of Life.The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice
P2860
Q27308039-9758EB18-B518-452F-929B-7344D71E093CQ28079603-0459E584-ACFD-4BCE-A374-B7A7FD87B33DQ33773490-D6A1EACD-3F6A-434F-9366-5F33C954FED0Q34558461-19C6BC63-C7AA-40E6-95FE-9CA73FB555FEQ34588469-5ACBB71D-27F9-42F6-A7A2-18483E1CF3E6Q35192530-F773F722-CB94-4DF5-A2B7-D20FA8C081D5Q35359425-47EECD0D-F805-4BFF-B122-CFA50564B814Q35738095-5C5F9612-2D1E-44A7-9F5A-95AD4D752D87Q35760437-573CA8F5-EF6E-43FE-9573-876D5396936AQ36116045-A11F6A15-91C4-4436-8C96-B8F2F242F652Q36305106-EDECD9CD-FABF-4AE3-9BD5-4ADEA6851552Q36339485-6DD94FDD-EBA0-47FC-98C3-00C46E97718AQ36565868-81FC313F-5C2E-48BC-BD9A-EAE8147AD4ECQ36829137-8DE53995-D59B-4148-8A10-12C0A321240BQ36917960-91F25C23-2D9B-44C1-A4FD-8B1A825B4988Q37081415-9FC1D2A8-F437-40CC-B261-AC6D91AC7F16Q37183375-D1DEF22F-5128-4F95-9674-BDC5B2EE538DQ37354260-EEA4659D-D128-4BF9-BEB0-754B8DD26FD9Q37731227-91F8C57E-3D78-48D0-80A2-5F38BC58404BQ39376362-ACC2D077-A441-48D3-A2D8-2B2BA253C6F3Q40666592-26C20776-50F5-4224-B450-B586CBE3E0BAQ41572699-E3A9CEE0-3B1A-4E34-8D86-B6A33773729CQ45193547-742A02F5-C55F-4C7E-953D-3C899E0E4F1DQ47845003-7B8E2757-2DE9-4D18-97F9-9960A5125BBDQ48157747-6A0DA4B6-F3E7-480C-B9DF-A7F04AF58A05Q50573929-915E0F68-6265-4FE6-836B-43174FEB01ADQ57115264-92AC7FB1-ED91-49F1-B8D6-9916F28CC96E
P2860
Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Diminazene aceturate enhances ...... duced cardiac pathophysiology.
@en
type
label
Diminazene aceturate enhances ...... duced cardiac pathophysiology.
@en
prefLabel
Diminazene aceturate enhances ...... duced cardiac pathophysiology.
@en
P2093
P2860
P1433
P1476
Diminazene aceturate enhances ...... nduced cardiac pathophysiology
@en
P2093
Andrew Espejo
Chunjuan Song
Colleen T Cole-Jeffrey
Juan Zhang
Michael J Katovich
Mina Hanna
Mohan K Raizada
Vinayak Shenoy
P2860
P304
P356
10.1161/HYPERTENSIONAHA.113.01337
P407
P577
2013-08-19T00:00:00Z